New Inversion Regs Won't Hinder $16.6B Johnson-Tyco Tie-Up
By Braden Campbell ( April 21, 2016, 1:45 PM EDT) -- The newly unveiled anti-tax inversion regulations that thwarted Pfizer Inc.'s plan to combine with Irish drugmaker Allergan PLC earlier this month will not do the same for Johnson Controls Inc.'s $16.6 billion tie-up with Ireland-based fire and security provider Tyco International PLC, the Milwaukee-based industrial company said in a regulatory filing on Thursday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.